Adaptive Biotechnologies

US · ADPT #2184 by market cap Listed 2019

26.28 -0.62 -2.30%

Live - 5344 symbols - heartbeat 293s ago · 2026-10-08 07:30

Pre-market 25.80 -1.83%

After-hours 26.28 0.00%

Overnight 26.15 -0.49%

Market cap: 4.19B
P/E (TTM): -65.70
P/B: 29.36
EPS: -0.39
Div yield: 0.00%
52W pos: 76%

Reader sentiment Are you bullish or bearish on ADPT?

Anonymous reader poll. Unscientific, not investment advice.

About Adaptive Biotechnologies

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.

Founded: 2009
CEO: Mr. Chad M. Robins
Employees: 624
Headquarters: Seattle, Washington, United States of America
Fiscal year end: 12-31
Website: adaptivebiotech.com

Company profile

Exchange: US
Symbol: ADPT
Market-cap rank: #2184
Listing date: 2019-06-27
Market cap: 4.19B
Float cap: 3.30B
Shares out: 159.60M
Float shares: 125.48M

Sectors & themes

Diagnostics & Research ARK Portfolio Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 07:30:14 · For reference only, not investment advice and not tailored to your situation.